Clinical Trials Browser

Phase 2/3 × Interventional × Squamous Cell Non-small Cell Lung Cancer × Clear all

NCT06319313 2024-03-20

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Phase 2/3 Not yet recruiting

Squamous Cell Non-small Cell Lung Cancer